Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.7600
+0.0098 (1.31%)
Aug 14, 2025, 1:40 PM - Market open
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $3.30 million as of August 14, 2025. Its market cap has increased by 10.01% in one year.
Market Cap
3.30M
Enterprise Value
-308.67K
1-Year Change
10.01%
Ranking
Category
Stock Price
$0.76
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $3.30M, a decrease of -98.41%. That is a compound annual growth rate of -74.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 3.26M | -66.66% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |